FAAS
BIIB icon

First Allied Advisory Services’s Biogen BIIB Stock Holding History

First Allied Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.28M Sell
4,497
-757
-14% -$211K 0.04% 408
2020
Q2 		$1.41M Sell
5,254
-393
-7% -$118K 0.05% 358
2020
Q1 		$1.79M Sell
5,647
-315
-5% -$95.6K 0.08% 265
2019
Q4 		$1.76M Sell
5,962
-2,751
-32% -$763K 0.06% 337
2019
Q3 		$2.02M Sell
8,713
-1,320
-13% -$307K 0.07% 299
2019
Q2 		$2.35M Sell
10,033
-625
-6% -$144K 0.08% 272
2019
Q1 		$2.5M Buy
10,658
+119
+1% +$37.5K 0.09% 252
2018
Q4 		$3.21M Sell
10,539
-711
-6% -$227K 0.13% 193
2018
Q3 		$3.96M Buy
11,250
+519
+5% +$179K 0.14% 176
2018
Q2 		$3.11M Sell
10,731
-608
-5% -$171K 0.12% 202
2018
Q1 		$3.1M Buy
11,339
+1,955
+21% +$607K 0.12% 195
2017
Q4 		$3.01M Buy
9,384
+302
+3% +$96.9K 0.12% 191
2017
Q3 		$2.86M Sell
9,082
-437
-5% -$129K 0.12% 187
2017
Q2 		$2.59M Buy
9,519
+283
+3% +$74.8K 0.12% 202
2017
Q1 		$2.55M Buy
9,236
+1,216
+15% +$344K 0.13% 176
2016
Q4 		$2.27M Sell
8,020
-335
-4% -$99.3K 0.11% 204
2016
Q3 		$2.62M Sell
8,355
-880
-10% -$261K 0.14% 175
2016
Q2 		$2.22M Buy
9,235
+712
+8% +$188K 0.12% 188
2016
Q1 		$2.22M Buy
8,523
+1,014
+14% +$268K 0.12% 187
2015
Q4 		$2.31M Buy
7,509
+1,707
+29% +$491K 0.12% 191
2015
Q3 		$1.7M Buy
5,802
+2,084
+56% +$688K 0.09% 250
2015
Q2 		$1.49M Buy
3,718
+550
+17% +$221K 0.07% 318
2015
Q1 		$1.34M Buy
3,168
+664
+27% +$262K 0.09% 266
2014
Q4 		$841K Buy
2,504
+1,148
+85% +$371K 0.06% 372
2014
Q3 		$452K Buy
1,356
+197
+17% +$65K 0.04% 545
2014
Q2 		$364K Buy
1,159
+146
+14% +$43.9K 0.03% 637
2014
Q1 		$308K Buy
1,013
+55
+6% +$17.5K 0.02% 709
2013
Q4 		$274K Buy
958
+39
+4% +$10.1K 0.02% 701
2013
Q3 		$209K Buy
+919
New +$206K 0.01% 867

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Allied Advisory Services's BIIB Position: Q3 2020 in Review

First Allied Advisory Services reduced its Biogen (BIIB) stake by 14% in Q3 2020, selling an estimated $211K and leaving 4,497 shares worth $1.28M. The position accounts for 0.04% of the portfolio, ranked #408.

First Allied Advisory Services first reported a position in BIIB in Q3 2013 and has held it in 29 quarters since. The position peaked at $3.96M in Q3 2018. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • First Allied Advisory Services held 4,497 shares of Biogen worth $1.28M as of Q3 2020.
  • First Allied Advisory Services sold 757 Biogen shares in Q3 2020, an estimated $211K.
  • Biogen made up 0.04% of First Allied Advisory Services's portfolio in Q3 2020, its #408 holding.
  • First Allied Advisory Services first reported a position in Biogen in Q3 2013 and has held it in 29 quarters since.
  • First Allied Advisory Services's Biogen position peaked at $3.96M in Q3 2018.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.